Equine TNFα antibody and antigen (recombinant protein)
Diagnostic anti-Equine TNFα antibodies pairs and antigen for animal health (animal Equine/Horse rheumatoid arthritis, ankylosing spondylitis, and Crohn’s disease) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-TNFa-Ag01 | Recombinant Equine TNFα protein | 3090 |
GMP-EQU-TNFa-Ab01 | Anti-Equine TNFα mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-TNFa-Ab02 | Anti-Equine TNFα mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-TNFa-Ab03 | Anti-Equine TNFα human monoclonal antibody (mAb) | 1953 |
GMP-EQU-TNFa-Ab04 | Anti-Equine TNFα human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-EQU-TNFa-Ag01 |
Product Name | Recombinant Equine TNFα protein |
Target/Biomarker | Equine tumor necrosis factor alpha (SAHH) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine tumor necrosis factor alpha antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in SAHH level test of animal Equine/Horse with rheumatoid arthritis, ankylosing spondylitis, and Crohn’s disease. |
Tag | His |
Products description | Recombinant Equine TNFα protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-TNFa-Ab01, GMP-EQU-TNFa-Ab02 |
Product Name | Anti-Equine TNFα mouse monoclonal antibody (mAb) |
Target/Biomarker | Equine tumor necrosis factor alpha (SAHH) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine tumor necrosis factor alpha antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-SAHH antibodies in SAHH level test of animal Equine/Horse with rheumatoid arthritis, ankylosing spondylitis, and Crohn’s disease. |
Tag | mFc |
Products description | Anti-Equine TNFα mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-SAHH antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-TNFa-Ab03, GMP-EQU-TNFa-Ab04 |
Product Name | Anti-Equine TNFα human monoclonal antibody (mAb) |
Target/Biomarker | Equine tumor necrosis factor alpha (SAHH) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Equine tumor necrosis factor alpha antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-SAHH antibodies in SAHH level test of animal Equine/Horse with rheumatoid arthritis, ankylosing spondylitis, and Crohn’s disease. |
Tag | hFc |
Products description | Anti-Equine TNFα human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-SAHH antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Tumor Necrosis Factor-alpha (TNFα), in the context of equines (horses), emerges as a multifaceted cytokine with a central role in orchestrating immune responses, inflammation, and tissue homeostasis. This pivotal biomarker belongs to the tumor necrosis factor superfamily, representing a critical arm of the equine immune system's defense mechanisms. Structurally, TNFα exists as a homotrimeric protein, and its functions span a spectrum of immune and inflammatory actions. It acts as a potent signaling molecule, binding to specific cell surface receptors, and initiating cascades of cellular responses. Its production is primarily attributed to immune cells within the horse's body, with macrophages and T cells being prominent sources.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.